Site Search
 

Lipemia (T173)

[Back]
RISK ASSESSMENT VALUE:  Lipemia in a serum sample is most commonly the result of a non-fasting status. There is a rare inherited metabolic disorder that results in the over production of fats in some people. An excessive amount of triglyceride in a serum sample is responsible for lipemia. Other laboratory results are known to be affected by lipemia. In non-fasting samples it is possible to separate out, via ultracentrifugation, the excess lipids and obtain more accurate values that approximate those found in a fasting sample. 15 minute ultracentrifugation will not separate serum lipids present in genetic hyperlipidemia.
NORMAL RESULTS:  The following tests are generally not affected: Glucose Creatinine Calcium GGTP Total Protein Cholesterol HDL (may show slight increase)
ABNORMAL RESULTS:  The following tests are usually flagged with an instrument error and require re-analysis either after ultracentrifugation or dilution: BUN SGOT SGPT LDH Bicarbonate The following tests are usually increased as a result of lipemia: Uric acid Bilirubin Albumin Fructosamine Triglyceride
ADDITIONAL TESTS:  Not applicable.
SAMPLE NEEDED:  Separated serum from a red-stopper tube.
SAMPLE STABILITY:  Ten (10)days at room temperature, 2 weeks when refrigerated and indefinite when frozen at <20?c.
METHOD & INSTRUMENT:  Methodology - Reagent Blank; Instrumentation - Hitachi Modular.
INTERFERING FACTORS:  If triglycerides are >400, the calculated tests (i.e. VLDL, LDL) are not reported. If triglycerides are >800, ultracentrifugation is performed. Results are reported on the clarified sample.
PURPOSE:  " To provide additional information to the underwriter in regards to specimen condition and the accuracy of laboratory results. " Method to reduce the affect of postprandial lipids on sample results.
PROFILE INCLUDES: 
EXPECTED RANGE:  0 - 45

Home | About Us | BioAnalytical | Clinical Trials | Genomics | Insurance | Toxicology | Wellness